Bio-IT World Conference & Expo to Host Third Annual Venture, Innovation & Partnering Conference in Boston

Cambridge Healthtech Institute has unveiled the program for the third annual Bio-IT World Venture, Innovation & Partnering Conference, which will take place on May 19 in Boston. The conference aims to bring together over 200 investors, corporate executives, entrepreneurs, and startups to facilitate connections between capital, technology, and science in order to expedite drug discovery.

Notable participants will include industry leaders from AstraZeneca, Breyer Capital, Eli Lilly and Company, MIT, and more. The event will feature Keynote Fireside Chats and sessions covering topics such as capital strategy, lab funding, VC and pharma collaboration, and the future of biomedical research and IT.

Attendees will also have the opportunity to engage in two days of educational sessions and networking at the Bio-IT World Conference & Expo, featuring over 200 presentations on advanced technologies driving progress in biomedical research, drug discovery, and clinical care. The larger event will commence with a keynote presentation on Research, Funding and Advocacy for Rare Diseases, followed by a welcome reception in the Exhibit Hall.

Registration for the conference and expo is now open.